Sencure is working on a sensor that picks up electrophysiological signals with fifteen times lower power consumption than competing solutions. This month, the startup successfully expanded its 2023 funding round to 7.9 million euros to bring its current proof of concept to market.
Sencure receives an additional investment of 3.9 million euros for the development of its electrophysiological sensor, which can measure heart signals (ECG), as well as brain waves (EEG) and muscle tension (EMG). The investment is an addition to the 4 million euros from 2023, provided by Cottonwood Technology Fund, 819 Capital Partners and the Investment and Development Agency for the Northern Netherlands (NOM). This round, the Belgian Bluegrass Ventures decided to join in as well.
Sencure’s chip uses up to fifteen times less power than comparable solutions from competitors without sacrificing the quality of the signal. “Potential applications include a patch that can take an ECG or measure muscle tension in people who had a stroke to assess how far they can rehabilitate, or glasses that measure brain waves,” says Dick van Waes, who now leads the startup based in Roden, Enschede and recently Nijmegen.
This article is exclusively available to premium members of Bits&Chips. Already a premium member? Please log in. Not yet a premium member? Become one for just €20 for the first year and enjoy all the benefits.
